top of page

Better Care, Everywhere

What if anyone could quickly, accurately, and cheaply identify any infection from the comfort of their own home?

​

Our mission is to democratize access to diagnostics with our state-of-the-art molecular testing platform.

OUR PRODUCTS

Our molecular diagnostic kits are programmable towards any DNA or RNA pathogen.

Highly specific and sensitive (several peer-reviewed papers), these one-pot, one-step tests are easy to adapt to any target and ready to be performed by anyone with no additional training.

WHY EN CARTA

Why En Carta

GROUNDBREAKING  TECHNOLOGY

Our lab-grade molecular tests detect pathogenic genetic information with PCR accuracy without the need for specialized equipment or medical professionals, while producing no toxic waste.

FAST PRODUCT DEVELOPMENT

Our development cycle is fast with in-silico discovery achievable in a matter of days.

We quickly develop exactly the diagnostic you are looking for.

DEEP TECH

Our products leverage the most cutting-edge synthetic biology technologies for diagnostics development today.

IMPACT AND SUSTAINABILITY

We are mindful of sustainability goals and aim to transform point-of-care diagnostics while creating a minimal carbon footprint.

OUR PARTNERS

wilco_logo_pink-new_2x.png
Arizona_State_University_old_signature.svg.png
LOGO_BPI.png
Test Tubes

LATEST PRODUCT

Lyme detection

We are developing a new generation of Lyme disease diagnostics.

​

The first test to detect the infection right at the tick bite, enabling early intervention and prevention of Lyme disease progression.

Our vision is to use our technology to develop point-of-care nucleic acid diagnostics for pathogens like HIV, TB, and HPV with specificity down to the single-nucleotide level and costs below $1.
These diagnostics will benefit from the extremely low cost of paper-based molecular systems, ensuring room temperature stability for up to a year.

En Carta Diagnostics

bottom of page